Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Da-xin Zhou"'
Autor:
Da-wei Lin, Zi-long Weng, Jia-ning Fan, Yu-liang Long, Li-hua Guan, Wen-zhi Pan, Da-xin Zhou, Jun-bo Ge
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 8, p 307 (2024)
Background: In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a pivotal treatment for pure native aortic regurgitation (PNAR). Given patients with severe aortic regurgitation (AR) are prone to suffer from pulmonary hyperte
Externí odkaz:
https://doaj.org/article/d1e8131cb2e748ff9eefb69e1a99e6fa
Autor:
Dong‐Xiang Zhong, Yuan Zhang, Qi Jin, Xiao‐Chun Zhang, Feng Zhang, Dan‐Dan Chen, Li‐Hua Guan, Da‐Xin Zhou, Jun‐Bo Ge
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-9 (2021)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important and major player in the pathophysiology of hypercholesterolemia and atherosclerosis. Recently, PCSK9 has been implicated in the pathogenesis of inflammatory diseases. Whether PCSK9
Externí odkaz:
https://doaj.org/article/aec1202252f64051aa1be205e469eeda
Publikováno v:
Cardiology Plus, Vol 6, Iss 2, Pp 102-108 (2021)
Background and Objectives: The anatomical characteristics of patients with mitral valve prolapse (MVP) and mitral regurgitation (MR) have rarely been investigated demographically to determine the applicability of transcatheter intervention. Therefore
Externí odkaz:
https://doaj.org/article/a819d4d7fd8642ab8eda639fd8b4f2db
Autor:
Li-Fan Yang, Wen-Zhi Pan, Li-Hua Guan, Xiao-Chun Zhang, Lei Zhang, Sha-Sha Chen, Da-Xin Zhou, Jun-Bo Ge
Publikováno v:
Cardiology Plus, Vol 6, Iss 3, Pp 181-186 (2021)
Objectives: Patients undergoing trans-carotid transcatheter aortic valve replacement (TC-TAVR) are more likely to suffer from a stroke because of cerebral blood hypoperfusion and blood occlusion caused by the introducer sheath compared with the trans
Externí odkaz:
https://doaj.org/article/a13f364952004a9490739078a87b5b11
Publikováno v:
Cardiology Plus, Vol 6, Iss 4, Pp 256-263 (2021)
Prognosis in subjects with coronary artery fistula (CAF) is highly variable. CAF may remain asymptomatic throughout the entire lifetime in some; however, in others, CAF may become hemodynamically significant and complications ensue. CAF closure, eith
Externí odkaz:
https://doaj.org/article/29e588b3055241f0b9b52aec78b7db30
Publikováno v:
Cardiology Plus, Vol 5, Iss 2, Pp 62-70 (2020)
In recent years, transcatheter treatment of mitral regurgitation (MR) has been extensively explored and has shown promising results. After transcatheter mitral valve repair (TMVr) with MitraClip has become a routine strategy in patients with symptoma
Externí odkaz:
https://doaj.org/article/bb322aec5ec5418a8021f6a6b62638d2
Publikováno v:
HeartRhythm Case Reports, Vol 2, Iss 2, Pp 187-189 (2016)
Externí odkaz:
https://doaj.org/article/d4c1af6cbac64a839f29c74a60e3c62a
Autor:
Da-Wei, Lin, Zi-Long, Weng, Yan-Xing, Fang, Jia-Ning, Fan, Yi-Ming, Qi, Zhi, Zhan, Yu-Liang, Long, Wen-Zhi, Pan, Da-Xin, Zhou, Jun-Bo, Ge
Publikováno v:
In The American Journal of Cardiology 1 July 2024 222:58-64
Autor:
Zhi-Cheng Jing, Maurice Beghetti, Da-xin Zhou, Dong Liu, Jie-Ming Qu, Xin Jiang, Qian-Qian Liu, Li-Hua Guan
Publikováno v:
International Journal of Cardiology, Vol. 211 (2016) pp. 132-6
Background Pulmonary arterial hypertension (PAH) frequently arises in patients with congenital heart disease (CHD) and can lead to pulmonary vascular disease (PVD). The present study was initiated to distinguish the predisposing effect of bone morpho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ba18124195b5df85adb4631992763c
https://archive-ouverte.unige.ch/unige:96724
https://archive-ouverte.unige.ch/unige:96724
Autor:
Dong Bao Zhao, Da Xin Zhou, Jie Yan Shen, Xian Sheng Cheng, Zhi-Cheng Jing, Hua Yao, Xin Pan, Hong Gu, Xian Yang Zhu, Zhuoli Zhang, Yong Wang, Geoff Strange, Mei Xiang Xiang, Yue Jin Yang, Brad Dalton, Zhen Kun Yang
Publikováno v:
The Journal of Heart and Lung Transplantation. 29:150-156
Bosentan has an established role in the management of pulmonary arterial hypertension (PAH). This clinical trial assessed the benefits of bosentan in the Chinese population.We investigated the efficacy and safety of bosentan in 92 Chinese citizens (m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590df6464d260c9dcaa9f890da0f5ce0
https://doi.org/10.1016/j.healun.2009.09.020
https://doi.org/10.1016/j.healun.2009.09.020